普瑞巴林联合硫辛酸对糖尿病痛性神经病变患者的影响

doi:10.20047/j.issn1673-7210.2023.09.15

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (668 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Pregabalin combined with Lipoic acid on patients with diabetic painful neuropathy. Methods A total of 86 patients with diabetic painful neuropathy admitted to the Seventh People’s Hospital of Chongqing from July 2019 to December 2020 were selected and divided into control group (43 cases) and experimental group (43 cases) according to random number table method. Both groups received conventional treatment, the control group was treated with Lipoic acid combined with Gabapentin, and the experimental group was treated with Lipoic acid combined with Pregabalin, the course of treatment was four weeks. The efficacy, numerical rating scale (NRS) score, Michigan diabetic neuropathy score (MDNS), and nerve conduction velocity before and after treatment were compared between the two groups. The occurrence of adverse drug reaction (ADR) was recorded in the two groups. Results After treatment, the therapeutic effect of experimental group was better than that of control group, and the difference was statistically significant (P＜0.05). After treatment, NRS scores and MDNS in two groups were lower than those before treatment, and experimental groups were lower than those of control group, and the differences were statistically significant (P＜0.05). After treatment, the motor nerve conduction velocity and sensory nerve conduction velocity of median nerve and common peroneal nerve in two groups were higher than before treatment, the differences were statistically significant (P＜0.05). There was no significant difference in the total incidence of ADR between the two groups (P＞0.05). Conclusion The treatment effect of Pregabalin combined with Lipoic acid is better than that of Lipoic acid combined with Gabapentine in patients with diabetic painful neuropathy, and the incidence of ADR is lower.

Key words： Pregabalin Lipoic acid Diabetic Painful neuropathy Nerve conduction velocity

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FU Xiaojuan1 LI Xunjun2 YU Jian3 YANG Zongfa1 JIANG Yuqin1

Cite this article:

FU Xiaojuan1 LI Xunjun2 YU Jian3 YANG Zongfa1 JIANG Yuqin1. Effect of Pregabalin combined with Lipoic acid on patients with diabetic painful neuropathy[J]. 中国医药导报, 2023, 20(9): 71-74,79.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.09.15 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I9/71

[1] 王柏荣，李全民.巨噬细胞炎症蛋白-1与痛性糖尿病周围神经病变的研究进展[J].中华糖尿病杂志，2020，12（4）：268-271.
[2] 王国凤，徐宁，汲广全，等.miR-146a多态性对硫辛酸治疗2型糖尿病患者糖尿病周围神经病变疗效的影响[J].中国糖尿病杂志，2021，29（5）：334-338.
[3] 李素芬，苏彩霞，周夫.硫辛酸联合依帕司他治疗2型糖尿病痛性神经病变临床效果及安全性分析[J].中国处方药，2019，17（12）：81-82.
[4] 陶宏，渠银平，王春奎.加巴喷丁与腺苷钴胺联合治疗糖尿病患者痛性神经病变的效果[J].中国卫生工程学，2019， 18（5）：770-772.
[5] 郜锦英，刘娟丽，程宏，等.普瑞巴林对PDPN患者正中神经、腓总神经传导速度及疼痛改善效果研究[J].陕西医学杂志，2018，47（4）：515-517.
[6] 沈雅舟，吴松华，邵福源，等.糖尿病慢性并发症[M].上海：上海医科大学出版社，1999：206-287.
[7] 黄宇光，徐建国.神经病理性疼痛临床诊疗学[M].北京：人民卫生出版社，2010：305.
[8] Williamson A，Hoggart B. Pain：a review of three commonly used pain rating scales [J]. J Clin Nurs，2005，14（7）：798- 804.
[9] 廖二元.内分泌学[M].北京：人民卫生出版社，2001：1563- 1564.
[10] 闫润香.不同评分量表在糖尿病周围神经病变筛查中的比较研究[J].中国综合临床，2014，30（4）：402-404.
[11] 周亚男，杨洁，王丽晖，等.百令片联合依帕司他治疗2型糖尿病周围神经病变患者临床效果及对氧化应激、炎症反应影响[J].临床误诊误治，2021，34（7）：29-33.
[12] 张芳，庞国明，倪青，等.降糖通络片对气虚血瘀证糖尿病周围神经病变氧化应激的影响[J].世界中西医结合杂志，2020，15（8）：1544-1546.
[13] 山永仪，李舜君，李冬萍，等.前列地尔联合马来酸桂哌齐特对2型糖尿病并发周围神经病变患者的临床疗效及对神经传导速度、氧化应激指标、胱抑素C水平的影响[J].中国老年学杂志，2020，40（7）：1390-1393.
[14] 时立新.糖尿病神经病变的机制与药物治疗[J].中华糖尿病杂志，2021，13（4）：446-448.
[15] 李东风，章秋.硫辛酸序贯疗法联合依帕司他治疗糖尿病痛性神经病变的临床研究[J].中国全科医学，2018， 21（26）：3175-3183.
[16] 任伟，郭剑津，高林琳，等.硫辛酸联合加巴喷丁或普瑞巴林治疗痛性糖尿病周围神经病变的疗效比较[J].中国药物与临床，2019，19（10）：1585-1588.
[17] 李彬彬，王民，田勇，等.依帕司他联合α-硫辛酸治疗老年糖尿病周围神经病变的临床效果[J].实用临床医学，2022，23（2）：16-19.
[18] 杨京利，马国平，谢鹏程，等.加巴喷丁联合小剂量丁丙诺啡透皮贴治疗糖尿病周围神经痛的临床分析[J].贵州医药，2021，45（6）：869-870.
[19] 袁丽，白亚菲，杨海波，等.加巴喷丁联合高能红光治疗痛性糖尿病周围神经病变患者的疗效观察[J].广西医学，2019，41（9）：1086-1090.
[20] 阎海洋，郑荐方，傅轶珊.311 nm窄谱中波紫外线联合加巴喷丁治疗带状疱疹后遗神经痛的临床效果[J].中国当代医药，2021，28（28）：40-42.
[21] 李阳，孔彩霞，肖方喜，等.加巴喷汀联合依帕司他治疗糖尿病痛性神经病变的效果[J].现代医学，2019，47（8）：935-939.
[22] 虞洁，朱黎焱，张方楹，等.普瑞巴林治疗糖尿病神经痛临床疗效及对血清IL-6、TNF-α水平的影响[J].浙江中西医结合杂志，2018，28（6）：467-469.
[23] 高莉，方向明，唐宇凤，等.恩格列净联合普瑞巴林治疗痛性糖尿病多发性神经病的疗效分析[J].中南医学科学杂志，2022，50（1）：75-77.
[24] 陈亮，王石荣，朱锦辉，等.普瑞巴林联合阿米替林治疗糖尿病周围神经痛的疗效观察[J].中国医院用药评价与分析，2019，19（1）：14-18.
[25] 韩俊萍，田如新，樊碧发，等.度洛西汀和普瑞巴林治疗糖尿病性周围神经病理性疼痛疗效与安全性比较的Meta分析[J].中国疼痛医学杂志，2020，26（5）：357- 361.